APIRx... sell retail?
I don't think you have a clue.
APIRx is biotech: their main assets are drug candidates and process IP: that didn't change when Incannex acquired them.
At the current hour, Incannex remains a pure play biotech. They didn't buy APIRx for the couple of gum products the company had brought to market, but for the 22 clinical and pre-clinical programs the company possesses. You would know this from even a cursory read of any of several company releases on the APIRx acquisition.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-15044
-
- There are more pages in this discussion • 4,853 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online